SPECTRAL AI, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
SPECTRAL AI, INC. (MDAI) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $298.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-11
- SPECTRAL AI, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $151.00K, a 8.63% increase year-over-year.
- SPECTRAL AI, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $147.00K, a 4.26% increase year-over-year.
- SPECTRAL AI, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $143.00K, a 10.00% increase year-over-year.
- SPECTRAL AI, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $141.00K, a 10.16% increase year-over-year.
- SPECTRAL AI, INC. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $564.00K, a 2.42% decline from fiscal 2024.
- SPECTRAL AI, INC. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $578.00K, a 18.93% decline from fiscal 2023.
- SPECTRAL AI, INC. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $713.00K.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $151.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $298.00K 10-Q · filed 2026-08-11 | $441.00K derived: sum of 3 quarters · filed 2026-08-11 | $582.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $147.00K 10-Q · filed 2026-05-13 | $290.00K derived: sum of 2 quarters · filed 2026-05-13 | $431.00K derived: sum of 3 quarters · filed 2026-05-13 | $570.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $143.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $284.00K derived: sum of 2 quarters · filed 2026-03-25 | $423.00K derived: sum of 3 quarters · filed 2026-08-11 | $564.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | $141.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $280.00K derived: sum of 2 quarters · filed 2026-08-11 | $421.00K 10-Q · filed 2025-11-13 | $551.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $139.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $280.00K 10-Q · filed 2026-08-11 | $410.00K derived: sum of 3 quarters · filed 2026-08-11 | $538.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $141.00K 10-Q · filed 2026-05-13 | $271.00K derived: sum of 2 quarters · filed 2026-05-13 | $399.00K derived: sum of 3 quarters · filed 2026-05-13 | $531.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $130.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $258.00K derived: sum of 2 quarters · filed 2026-03-25 | $390.00K derived: sum of 3 quarters · filed 2026-03-25 | $578.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | $128.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $260.00K derived: sum of 2 quarters · filed 2025-11-13 | $448.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $132.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $320.00K 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $188.00K 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | $713.00K 10-K · filed 2025-03-31 | |||
| 2023-06-30 | $350.00K 8-K · filed 2023-09-15 | |||
| 2022-06-30 | $251.00K 8-K · filed 2023-09-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |